Mar 30, 2008

FDA Hails New Therapeutic

Shaken Stockholder Syndrome has now been addressed by Fong Pharmaceuticals, the company that brought you Constipation Relief Alleviating Patients(CRAP). The FDA allows CRAP to fly right through the approval process, so it was no surprise that our latest efforts squeezed out another winner. Shaken stockholder syndrome is best served by partnering with Big Pharma while being "advised" by a consortium of fee generating Wall Street advisors. It is neither safe nor efficacious but once these guys have a piece of the action and the FDA sees that, they can do nothing but approve. We like to call our product SCUM(Shareholders Can't Underrate Manipulators). Purchase some SCUM now before its too late. Shareholders that do will no longer have to shake when seeking approval for their Company's product.

No comments: